National Comprehensive Cancer Network

About NCCN

Newsroom

For inquiries, interviews, and media passes, contact:
Katie Kiley Brown, NCCN Communications Manager
215.690.0238
brown@nccn.org

Click here to be added to the NCCN Media List

Media Kit

• About NCCN – Mission and Vision
• Fact Sheet
• NCCN Member Institutions
• Leadership Bios
• Source List
• 2016 Annual Report
• History
• 20-Year Timeline
• NCCN Foundation

Upcoming Events for Media

Media Advisories

• Appropriate Distress Screening and Follow Up Leads to Fewer ER Visits and Hospitalizations in Patients with Cancer, Study Finds  (07/13/2017)
• NCCN Awards Grants to Investigators at Member Institutions to Study Osimertinib in Lung Cancer  (05/25/2017)
• NCCN Publishes New Patient Education Resources for Thyroid Cancer—One of the Most Commonly Diagnosed Cancers in Women in the United States  (05/12/2017)
• Despite Evidence that It Benefits Patients with Cancer, Study Finds Most Oncologists Don’t Discuss Exercise with Patients  (05/11/2017)

View more >

Press Releases

• NCCN Guidelines to Include Categories of Preference  (09/15/2017)
• NCCN Announces First Patient Dosed in NCCN-Peregrine Pharmaceuticals Collaborative Study of Bavituximab   (09/07/2017)
• NCCN Chemotherapy Order Templates to be Integrated into MEDITECH’s Web EHR  (09/07/2017)
• NCCN Guidelines to be Integrated into the Evinance Decision Support Platform  (08/23/2017)

View more >

NCCN in the News

• Few Women with History of Breast and Ovarian Cancer Take Recommended Genetic Test (UCLA Fielding School of Public Health)  (08/18/2017)
• September is Prostate Cancer Awareness Month (WOAY-TV ABC)  (08/18/2017)
• New NCCN Patient Resources for Rectal Cancer Now Available  (08/11/2017)
• Black Men Have Lowest Survival Rates Among Patients with Anal Cancer  (08/09/2017)

View more >

NCCN Member Institutions the News

• NCCN Announces First Patient Dosed in NCCN-Peregrine Pharmaceuticals Collaborative Study of Bavituximab   (09/07/2017)
• Link between Air Pollution and Cancer Risk (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)  (08/18/2017)
• GIST Tumors Linked To NF1 Mutations, Genetic Testing Needed (UC San Diego Moores Cancer Center)  (08/18/2017)
• Lab Tests Show Molecule Appears to Spur Cell Death in Tumors, Inflammation (Duke Cancer Institute)  (08/17/2017)

View more >